Managing Director explains why Swipha shut down its operations

The management of Swiss Pharma (Swipha) Nigeria Limited has explained why it decided to temporarily shut down its operations in Nigeria because of the uncooperative attitude of its staff who embarked on strike since mid December, protesting against the layoff of some workers by the company in order to strengthen its operations in Nigeria.

The Managing Director of Swipha, Gaby El Khoury in a released statement said the critical decision had to be taken to safe the company’s property and equipment from being damaged by the workers who allegedly stopped being committed to the company since it laid off some of the workers.

According to El Khoury, the sack was prompted by the fact that Swiss Pharma was acquired by Biogram, a subsidiary of the second largest pharmaceutical company in France, Servier and decided to restructure the organisation to ensure efficiency by removing superfluous staff and eventually align the firm with global best practices.

“Despite the tough economic situation in Nigeria, Biogaran, a subsidiary of Servier (the No. 2 French Pharmaceutical Group) that specialises in generics acquired Swiss Pharma Nigeria Limited (swipha) in March 2017, as part of its expansion plans to other African countries.
“Biogaran trusts Nigeria and Nigerian people, and wishes to provide through Swipha to all Nigerians access to quality and affordable medicines. The decision to buy Swipha was taken despite the poor situation of the company which was at the period, short in cash and under threat of closure.
“Upon inception, the new management decided to lift the company up to its Group compliance and social policies, corporate governance and benefits for the employees. Management decided to restructure the organisation to ensure efficiency by removing superfluous staff and eventually align the firm with global best practices,” El Khoury said in the statement.

For the Swipha boss, these policies appear to be unacceptable to some members of staff who preferred to slow down, “then to hinder operation and embarked on strike since mid-December 2017 while all efforts to make them have a rethink about a promising future proved abortive.”

He said to safeguard company properties and prevent any form of hostility the management decided to officially shut-down operations temporarily.

“The new management of Swipha strongly believes in Nigeria and is committed to its economic development and is resilient in its quest to engage modern new ways of working, best in class practices and high-level compliance standards, notwithstanding the financial loses the company may incur during this time. It is committed to doing all it takes to ensure that the company maintains and strengthens its position as a leader in the pharmaceutical sector,”

Swiss Pharma Nigeria Limited otherwise known as “Swipha” was established in 1976 and has been supplying drugs to Federal Ministry of Health, State Governments, Parastatals and private Market. The company manufactures, markets, and distributes pharmaceutical products that meet international standards.